Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Iradimed Corp (IRMD)

224 + Investors. Track Smart Money conviction in IRMD. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
3Q ▲
Buyers last Q
57%

Smart Money Signals — IRMD

Based on 225 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added IRMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
225 hedge funds hold IRMD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +36% more funds vs a year ago

fund count last 6Q
+59 new funds entered over the past year (+36% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 57% buying

118 buying90 selling
Last quarter: 118 funds bought or added vs 90 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-17 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 13 → 37 → 49 → 32. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

45% of holders stayed for 2+ years

45% conviction (2yr+) 26% medium 28% new
102 out of 225 hedge funds have held IRMD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

21 → 13 → 37 → 49 → 32 new funds/Q
New funds entering each quarter: 13 → 37 → 49 → 32. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 57% veterans vs 29% newcomers

57% veterans 14% 1-2yr 29% new
Entry-cohort mix of 229 holders: 130 (57%) are 2+ year veterans, 33 entered 1–2 years ago, and 66 (29%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

Strong quality — 29% AUM from major funds

29% from top-100 AUM funds
48 of 225 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IRMD

In 2026 Q1, 118 hedge funds were net buyers of IRMD (32 opened a new position, 86 added to an existing one), while 90 reduced or exited (70 trimmed, 20 sold completely) — a 57% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 29% of total institutional value in IRMD is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 225.

Hedge Fund Ownership: IRMD

How many hedge funds hold IRMD — quarterly history vs. share price
Quarterly hedge fund ownership of IRMD vs. share price

Market Analysis: IRMD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IRMD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Iradimed Corp (IRMD) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IRMD has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 84d ago
IRMD
-4.1%
XLV
+2.8%

IRMD outperformed XLV by -6.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 39d ago
IRMD
+6.4%
XLV
+3.9%

Since the filing became public, IRMD outperformed XLV by +2.5% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

21 top-rated funds 1 high-conviction
Consensus
5.8
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: IRMD
224 + Investors

Track Smart Money conviction in IRMD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 224 213 5.16%
13F Shares 8M 7M 6.7%
Total Value $681M $701M -2.92%
New Positions 31 49 -18
Increased Positions 86 65 +21
Closed Positions 20 16 +4
Reduced Positions 69 71 -2
Total Calls 2 0 100%
Total Puts 2 0 100%
PUT/CALL Ratio 1.0 0.0 Neutral

Statistics: IRMD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

224 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IRMD. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IRMD holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Nine Ten Capital Management LLC 10.23% 334,488 $32.2M
2 Shaker Investments LLC/Oh 2.63% 60,040 $5.8M
3 Bridge City Capital, LLC 1.94% 72,573 $7.0M
4 Ballast Asset Management, LP 1.59% 37,107 $3.6M
5 Camarda Financial Advisors, LLC 1.47% 28,990 $2.8M
6 Albert D Mason Inc 1.07% 17,171 $1.7M
7 Davidson Capital Management Inc. 0.96% 55,022 $5.3M
8 Ranger Investment Management, L.P. 0.77% 111,085 $10.7M
9 Copeland Capital Management, LLC 0.77% 359,325 $34.6M
10 Aristides Capital LLC 0.63% 30,083 $2.9M
11 Uniplan Investment Counsel, Inc. 0.61% 62,141 $6.0M
12 Informed Momentum Co LLC 0.56% 49,995 $4.8M
13 Isthmus Partners, LLC 0.26% 25,693 $2.5M
14 Globeflex Capital L P 0.23% 15,546 $1.5M
15 Ellsworth Advisors, LLC 0.20% 11,151 $1.1M
16 Rice Hall James & Associates, LLC 0.19% 36,289 $3.5M
17 Oak Ridge Investments LLC 0.19% 29,429 $2.8M
18 Yorktown Management & Research Co Inc 0.18% 2,250 $217K
19 Silver Coast Investments LLC 0.11% 3,710 $357K
20 Cim, LLC 0.11% 7,723 $743K
21 Kayne Anderson Rudnick Investment Management LLC 0.10% 349,316 $33.6M
22 Punch & Associates Investment Management, INC. 0.09% 17,000 $1.6M
23 Virtus Advisers, LLC 0.07% 1,650 $159K
24 Riverwater Partners LLC 0.07% 2,285 $220K
25 Renaissance Technologies LLC 0.07% 440,712 $42.4M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Iradimed Corp (IRMD)

What does the Smart Money Trend signal show for IRMD?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added IRMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IRMD?

Slight buying edge — 57% buying: Last quarter: 118 funds bought or added vs 90 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for IRMD holders?

Strong quality — 29% AUM from major funds: 48 of 225 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held IRMD?

45% of holders stayed for 2+ years: 102 out of 225 hedge funds have held IRMD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Iradimed Corp (IRMD) following the 2026 Q1 hedge fund 13F filings?

As of today, IRMD has moved +6.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +2.5%. Since the quarter end (March 31, 2026), IRMD has gained -4.1% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →